Salts of 3- (1H-ind0l-3-yl) -4- [2- (4methyl-piperazin-i-yl) -quinazolin-4-yl] - pyrrole-2, 5-di one

Details for Australian Patent Application No. 2008226645 (hide)

Owner Novartis AG

Inventors Yowell, Guy; Papoutsakis, Dimitris; Karpinski, Piotr

Agent Davies Collison Cave

Pub. Number AU-B-2008226645

PCT Pub. Number WO2008/112479

Priority 60/893,954 09.03.07 US

Filing date 6 March 2008

Wipo publication date 18 September 2008

Acceptance publication date 20 September 2012

International Classifications

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 37/00 Drugs for immunological or allergic disorders

Event Publications

24 September 2009 PCT application entered the National Phase

  PCT publication WO2008/112479 Priority application(s): WO2008/112479

20 September 2012 Application Accepted

  Published as AU-B-2008226645

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008226649-Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof

2008226639-Compounds for the treatment of hepatitis C